Systemic treatment of advanced colorectal cancer: tailoring therapy to the tumor.
about
Genetics and Genetic Biomarkers in Sporadic Colorectal CancerEfficacy of Adjuvant 5-Fluorouracil Therapy for Patients with EMAST-Positive Stage II/III Colorectal Cancer.One colon lumen but two organs.Biomarker-directed Targeted Therapy in Colorectal Cancer.Histone H3K27 Trimethylation Modulates 5-Fluorouracil Resistance by Inhibiting PU.1 Binding to the DPYD Promoter.Multi-omics landscapes of colorectal cancer subtypes discriminated by an individualized prognostic signature for 5-fluorouracil-based chemotherapy.Mitochondrial protein 18 (MTP18) plays a pro-apoptotic role in chemotherapy-induced gastric cancer cell apoptosis.Proteomics, genomics, and molecular biology in the personalized treatment of colorectal cancer.Production of truncated MBD4 protein by frameshift mutation in DNA mismatch repair-deficient cells enhances 5-fluorouracil sensitivity that is independent of hMLH1 status.Effect of early preoperative 5-fluorouracil on the integrity of colonic anastomoses in rats.Secondary Prevention of Colorectal Cancer: Is There an Optimal Follow-up for Patients with Colorectal Cancer?Antitumor activity of HPA3P through RIPK3-dependent regulated necrotic cell death in colon cancer.Pramlintide, an antidiabetic, is antineoplastic in colorectal cancer and synergizes with conventional chemotherapy.Computational analysis of mRNA expression profiles identifies a novel triple-biomarker model as prognostic predictor of stage II and III colorectal adenocarcinoma patients
P2860
Q28084346-1856E852-F394-484D-A4A7-8012792CDF3BQ35634258-C7D43FB5-8707-4801-9997-41729D4D62A1Q36179345-5B2FB2CC-24D8-425B-8161-B51DE41D1B7AQ38383343-B7CCEE40-734E-406C-80B1-45A989C20F01Q39437966-059FCC48-C02D-48DC-B7AE-5CB983E59CCBQ39590420-578220E3-1D55-4C19-8883-F1D76FEC967EQ41345691-26F6E9EC-09B4-419C-B181-837B9EF2AB07Q41957159-2E431288-4F1E-408A-B920-F880FFB01CF8Q42386247-D73B1D75-8692-4AD5-8B0A-A00A585A8FE9Q42547579-14868707-BA22-4D4E-A100-C082A9ACB0E5Q42921554-3078F113-F799-4570-B57B-D94B1C85F680Q51746738-815AF57A-0E30-426C-AC32-71AF522431D9Q52649897-86F430A1-2E04-445B-86FA-DD7BD1E6FF44Q58698551-F6174005-F174-49AD-A722-23AE171177F0
P2860
Systemic treatment of advanced colorectal cancer: tailoring therapy to the tumor.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Systemic treatment of advanced colorectal cancer: tailoring therapy to the tumor.
@ast
Systemic treatment of advanced colorectal cancer: tailoring therapy to the tumor.
@en
Systemic treatment of advanced colorectal cancer: tailoring therapy to the tumor.
@nl
type
label
Systemic treatment of advanced colorectal cancer: tailoring therapy to the tumor.
@ast
Systemic treatment of advanced colorectal cancer: tailoring therapy to the tumor.
@en
Systemic treatment of advanced colorectal cancer: tailoring therapy to the tumor.
@nl
prefLabel
Systemic treatment of advanced colorectal cancer: tailoring therapy to the tumor.
@ast
Systemic treatment of advanced colorectal cancer: tailoring therapy to the tumor.
@en
Systemic treatment of advanced colorectal cancer: tailoring therapy to the tumor.
@nl
P2860
P356
P1476
Systemic treatment of advanced colorectal cancer: tailoring therapy to the tumor.
@en
P2093
John M Carethers
P2860
P356
10.1177/1756283X08093607
P577
2008-07-01T00:00:00Z